FCGR2APolymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor (Q57239064)
article by Nai-Kong V. Cheung et al published 20 June 2006 in Journal of Clinical Oncology
Language:
Current Data About FCGR2APolymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor
(P31) (Q13442814)

(P50) (Q56427012)
(P1932) Richard Gorlick
(P1545) 6

(Q20055453)
(P1932) Andrew J. Vickers
(P1545) 3

(Q88954512)
(P1545) 1
(P1932) Nai-Kong V. Cheung

(Q91473821)
(P1545) 4
(P1932) Irene Y. Cheung

(Q114536202)
(P1545) 5
(P1932) Brian H. Kushner

(P304) 2885-2890

(P407) (Q1860)

(P433) 18

(P478) 24

(P577) Tuesday, June 20, 2006

(P921) (Q184204)
(P887)

(Q79460)
(P887)

(Q1427096)
(P887)

(Q938205)
(P887)

(P1433) (Q400292)

(P1476) "FCGR2APolymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor" (language: en)

(P2093) Rebecca Sowers
(P1545) 2

other details
description article by Nai-Kong V. Cheung et al published 20 June 2006 in Journal of Clinical Oncology

External Links
(P356) 10.1200/JCO.2005.04.6011
(P698) 16682723